Geralyn S. Ritter is senior vice president at Merck & Co., Inc. and has been appointed executive vice president external affairs and corporate governance at Organon & Co., the new company that is planned to spin-off from Merck in 2021. Ritter served as corporate secretary of Merck from 2012-2020, and led corporate governance at the company, advising both senior management and the board of directors. Ritter also led engagement with the company’s major shareholders on a wide array of governance matters.
Earlier in her career at Merck, Ritter served as senior vice president of global public policy and president of the Merck Foundation. Prior to Merck, she was senior vice president for international affairs at PhRMA and also worked at the Office of the U.S. Trade Representative and Covington & Burling.